Management of HIV in resource-poor countries, with a focus on sub-Saharan Africa

Leprosy Review

Volumn 73, Issue 3, 2002, Pages 268-275

  Harries, A D ^a  

^a British High Commission Lilongwe   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; CYTOTOXIC AGENT; FANSIDAR; FLUCONAZOLE; ISONIAZID; METRONIDAZOLE; VINCRISTINE;

AFRICA SOUTH OF THE SAHARA; AIDS RELATED COMPLEX; HEALTH CARE PLANNING; HEALTH PROGRAM; HOME CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; KAPOSI SARCOMA; PALLIATIVE THERAPY; POVERTY; RESOURCE ALLOCATION; REVIEW; SCREENING TEST; TUBERCULOSIS;

AFRICA SOUTH OF THE SAHARA; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; PREVENTIVE HEALTH SERVICES;

EID: 0036745701     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. UNAIDS. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 2000.
2. Laga M, Alary M, Nzila N et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet, 1994; 344: 246-248.
3. Mulder D, Nunn A, Kamdi A, Kengeya-Kayondo J. Decreasing HIV-1 seroprevalence in young adults in a rural Ugandan cohort. BMJ, 1995; 311: 833-836.
4. Grosskurth H, Mosha A, Todd J et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet, 1995; 346: 530-536.
5. Working Group on Mother-To-Infant Transmission of HIV. Rates of mother-to-infant transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal sites. J Acquir Immun Defic Syndr Retrovirol, 1995; 8: 506-510.
6. Guay LA, Musoke P, Feling T et al. Intrapartum and neonatal single-dose nevirapine compare with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999; 354: 795-802.
7. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet, 2000; 355: 2237-2244.
8. Moore A, Herrera G, Nyamongo J et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet, 2001; 358: 657-660.
9. The Voluntary HIV-1 Counselling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania and Trinidad: a randomised trial., Lancet, 2000; 356: 103-112.
10. Sweat M, Gregorich S, Sangiwa G et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet, 2000; 356: 113-121.
11. UNAIDS. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 1998.
12. Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med, 1998; 338: 853-860.
13. Horton R. African AIDS beyond Mbeki: tripping into anarchy. Lancet, 2000; 356: 1541-1542.
14. Grant AD, Sidibe K, Domoua K et al. Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis, 1998; 2: 926-934.
15. Lucas SB, Hounnou A, Peacock C et al. The mortality and pathology of HIV infection in a West African city. AIDS, 1993; 7: 1569-1579.
16. Morgan D, Mande GH, Malamba SS et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet, 1997; 350: 245-250.
17. Global Programme on AIDS. Guidelines for the clinical management of HIV infection in adults. WHO/GPA/IDS/ HCS/91.6, World Health Organization, Geneva, 1991.
18. WHO Report 2001. Global tuberculosis control. Communicable diseases. WHO/CDS/TB/2001.287, World Health Organization, Geneva, 2001.
19. Maher D, Mwandumba H. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J Infect, 1994;28: 59-64.
20. Wiktor SZ, Sassan-Morroko M, Grant AD et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet, 1999; 353: 1469-1475.
21. Anglaret X, Chene G, Attia A et al. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Cote d'Ivoire: a randomised trial. Lancet, 1999; 353: 1463-1468.
22. Provisional WHO/UNAIDS secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. UNAIDS, Geneva, Switzerland. 2000.
23. Iyer JK, Milhous WK, Cortese JF et al. Plasmodium falciparum cross resistance between trimethoprim and pyrimethamine. Lancet, 2001; 358: 1066-1067.
24. Badri M, Ehrlich R, Wood R, Maartens G. Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations. AIDS, 2001: 15: 1143-1148.
25. Wilkinson D, Squire SB, Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ, 1998; 317: 625-629.
26. Fitzgerald DW, Desvarieux M, Severe P et al. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet, 2000; 356: 1470-1474.
27. Quinn TC, Wawer MJ, Sewankambo N et al. Viral load and heterosexual transmission of human immuodeficiency virus type. N Engl J Med, 2000; 342: 921-929.
28. Kumar S. Indian company offers low cost AIDS drugs. Lancet, 2001; 357: 616.
29. Harries AD, Nyangulu DS, Hargreaves NJ et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet, 2001; 358: 410-414.
30. Farmer P, Leandre F, Mukherjee JS et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet, 2001; 358: 404-409.
31. Attaran A, Sachs J. Defining and refining international donor support for combating the AIDS epidemic. Lancet, 2001; 357: 57-61.
32. Schwartlander B, Stover J, Walker N et al. Resource needs for HIV/AIDS. Sciencexpress, 2001; 21 June: 1/10.1126.
33. Brugha R, Walt G. A global health fund: a leap of faith? BMJ, 2001; 323: 152-154.